Richard A. Rifkind

Overview

Best Publications

• Histone deacetylases and cancer: causes and therapies.

  Paul A. Marks;Richard A. Rifkind;Victoria M. Richon;Ronald Breslow

  2878
  Citations

• Structures of a histone deacetylase homologue bound to the TSA and SAHA inhibitors.

  Michael S. Finnin;Jill R. Donigian;Alona Cohen;Victoria M. Richon

  2525
  Citations

• A class of hybrid polar inducers of transformed cell differentiation inhibits histone deacetylases

  Victoria M. Richon;Stephane Emiliani;Eric Verdin;Yael Webb

  1193
  Citations

• Histone deacetylase inhibitors as new cancer drugs.

  Paul A. Marks;Victoria M. Richon;Ronald Breslow;Richard A. Rifkind

  811
  Citations

• The histone deacetylase inhibitor SAHA arrests cancer cell growth, up-regulates thioredoxin-binding protein-2, and down-regulates thioredoxin

  Lisa M. Butler;Xianbo Zhou;Wei-Sheng Xu;Howard I. Scher

  664
  Citations

• Second generation hybrid polar compounds are potent inducers of transformed cell differentiation.

  V M Richon;Y Webb;R Merger;T Sheppard

  651
  Citations

• A new group of potent inducers of differentiation in murine erythroleukemia cells.

  Roberta C. Reuben;Richard L. Wife;Ronald Breslow;Richard A. Rifkind

  491
  Citations

• The histone deacetylase inhibitor suberoylanilide hydroxamic acid induces differentiation of human breast cancer cells.

  Pamela N. Munster;Tiffany Troso-Sandoval;Neal Rosen;Richard Rifkind

  481
  Citations

• Histone deacetylase inhibitors induce remission in transgenic models of therapy-resistant acute promyelocytic leukemia.

  Li-Zhen He;Thomas Tolentino;Peter Grayson;Sue Zhong

  379
  Citations

• Cloning and characterization of a histone deacetylase, HDAC9

  Xianbo Zhou;Paul A. Marks;Richard A. Rifkind;Victoria M. Richon

  372
  Citations

• Novel potent inducers of terminal differentiation and methods of use thereof

  Ronald Breslow;Paul A. Marks;Richard A. Rifkind;Branko Jursic

  307
  Citations

• Tumor promoters inhibit spontaneous and induced differentiation of murine erythroleukemia cells in culture

  H Yamasaki;E Fibach;U Nudel;I B Weinstein

  306
  Citations

• Induction of erythroid differentiation in murine virus infected eythroleukemia cells by highly polar compounds.

  Masao Tanaka;Joseph Levy;Masaaki Terada;Ronald Breslow

  305
  Citations

• Heinz body anemia: an ultrastructural study. II. Red cell sequestration and destruction.

  Richard A. Rifkind

  264
  Citations

• Effect of Hexamethylene Bisacetamide on the Commitment to Differentiation of Murine Erythroleukemia Cells

  Eitan Fibach;Roberta C. Reuben;Richard A. Rifkind;Paul A. Marks

  257
  Citations

• Changes in gene expression associated with induced differentiation of erythroleukemia: protooncogenes, globin genes, and cell division.

  Robert G. Ramsay;Kazuma Ikeda;Richard A. Rifkind;Paul A. Marks

  247
  Citations

• Induction of Transformed Cells to Terminal Differentiation and the Modulation of Gene Expression

  Paul A. Marks;Michael Sheffery;Richard A. Rifkind

  228
  Citations

• An ultrastructural study of early morphogenetic events during the establishment of fetal hepatic erythropoiesis.

  Richard A. Rifkind;David Chui;Hazel Epler

  216
  Citations

• The histone deacetylase inhibitor, CBHA, inhibits growth of human neuroblastoma xenografts in vivo, alone and synergistically with all-trans retinoic acid.

  Dennis C. Coffey;Martha C. Kutko;Richard D. Glick;Lisa M. Butler

  205
  Citations

• Novel class of cytodifferentiating agents and histone deacetylase inhibitors, and methods of use thereof

  Ronald Breslow;Sandro Belvedere;Leland Gershell;Thomas A. Miller

  197
  Citations